Document is current
Any future updates will be listed below
-
Authors
Bermúdez-Méndez, Erick
Lenart, Klara
Arcoverde Cerveira, Rodrigo
Engstrand, Olivia
Hellgren, Fredrika
Cagigi, Alberto
Ols, Sebastian
Jasny, Edith
Reinhardt, Annika
Petsch, Benjamin
Loré, Karin
-
Funding
Funding for this research was provided by:
Karolinska Institutet (Intramural faculty salary grant)
Karolinska Institutet (Intramural faculty salary grant)
Bill & Melinda Gates Foundation (OPP1192908)
Swedish Research Council (2023-02396)
- License Information
-
More Information
Article History
Received: 5 January 2026
Accepted: 13 May 2026
First Online: 26 May 2026
Competing interests
: E.J. and B.P. are current or former employees of CureVac SE, a company developing mRNA based vaccines and immunotherapeutics, which developed the influenza mRNA vaccine evaluated in this study. All other authors declare no competing financial or non-financial interests.
